Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Acer Therapeutics Inc (ACER)

Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Acer Therapeutics Inc ONE GATEWAY CENTER SUITE 356 300 WASHINGTON STREET NEWTON MA 02458 USA

www.acertx.com P: 844-902-6100

Description:

Acer Therapeutics Inc. is a pharmaceutical company. It develops therapies for the treatment of ultra-rare diseases with critical unmet medical need. The company's product pipeline consists of Edsivo (TM) and ACER-001 which are in clinical stage. Acer Therapeutics Inc., formerly known as Opexa Therapeutics, Inc., is based in Cambridge, United States.

Key Statistics

Overview:

Market Capitalization, $K 16,149
Enterprise Value, $K 13,819
Shares Outstanding, K 24,464
Annual Sales, $ 0 K
Annual Net Income, $ -26,240 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,090 K
EBIT, $ -19,780 K
EBITDA, $ -19,710 K
60-Month Beta 0.44
% of Insider Shareholders 20.20%
% of Institutional Shareholders 17.21%
Float, K 19,522
% Float 79.80%
Short Volume Ratio 0.68

Growth:

1-Year Return -44.06%
3-Year Return -74.61%
5-Year Return -97.12%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 58.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.53 on 11/20/23
Next Earnings Date 06/17/24 [--]
Earnings Per Share ttm 0.22
EPS Growth vs. Prev Qtr -130.43%
EPS Growth vs. Prev Year -70.97%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 20-207 on 09/21/17

ACER Ratios

Ratio
Price/Earnings ttm 3.66
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.93%
Return-on-Assets % 46.17%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.42
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar